Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

19.71
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
8.31
Today|||52-Week Range
22.81
+35.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues2.4B2.1B2.2B2.2B
 
 
 
 
 
Cost of Goods Sold615.3M557.0M602.0M618.0M
 
 
 
 
 
Depreciation And Amortization706.7M674.0M667.0M698.0M
 
 
 
 
 
 
Operating ExpensesGross Income1.1B878.0M964.0M903.0M
 
 
 
 
 
General Expenses758.0M757.0M753.0M704.0M
 
 
 
 
 
Research And Development93.0M96.0M94.0M81.0M
 
 
 
 
 
Total Operating Expenses2.1B2.0B2.0B2.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income323.0M121.0M211.0M199.0M
 
 
 
 
 
Extraordinary Credit31.0M10.0M49.0M238.0M
 
 
 
 
 
Extraordinary Charge-208.2M-300.0M-137.0M-728.0M
 
 
 
 
 
Interest Expense On Debt467.5M474.0M459.0M459.0M
 
 
 
 
 
Other Expenses-40.8M345.0M91.0M347.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-360.0M-295.0M-242.0M-400.0M
 
 
 
 
 
Income Taxes-152.0M-924.0M-205.0M-1.7B
 
 
 
 
 
Minority Interest-3.0M-1.0M-1.0M-1.0M
 
 
 
 
 
Net Income-515.0M628.0M-38.0M1.3B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS349.6M349.8M350.1M350.4M
 
 
 
 
 
Shares To Calculate EPS Diluted349.6M350.5M350.1M352.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.47$1.80-$0.11$3.71
 
 
 
 
 
EPS Diluted-$1.47$1.79-$0.11$3.69